Cancer Genomics Consortium — Aventa Genomics Stop by Booth #12 to learn how the Aventa FusionPlus and Aventa Lymphoma tests can help detect actionable fusions and rearrangements in FFPE tumor samples that are missed by other clinical tes...

Attending the CGC Conference? Visit us at Booth #12 to see how Aventa FusionPlus + Aventa Lymphoma tests uncover actionable fusions and rearrangements missed by other methods.

We will also be presenting on Redefining Cancer Diagnostics: How Hi-C Unlocks More from FFPE Testing

RSVP: bit.ly/46BtBcb

Rewriting Cancer Detection: Hi-C Technology Uncovers Gene Fusions Missed by Standard Methods Read our atest study, now online in The Journal of Molecular Diagnostics, where we demonstrate how Hi-C sequencing enables genome-wide structural variant detection in FFPE solid tumor specimens—with h...

Discover how @nyulangone.bsky.social, @childrenscolo.bsky.social, @ucsdcancer.bsky.social, @scrippshealth.bsky.social used Arima Genomics’ Hi-C technology to detect gene fusions and chromosomal rearrangements in FFPE tumor specimens: bit.ly/4l58vX5

#CancerResearch #PrecisionOncology